Approaches to Prevention of Cardiovascular Complications and Events in Diabetes Mellitus
The DOI matches its Crossref record; 259 of the 263 references it cites were found in a registry or an index.
Abstract
Diabetes mellitus affects about 8% of the adult population. The estimated number of patients with diabetes, presently about 170 million people, is expected to increase by 50-70% within the next 25 years. Diabetes is an important component of the complex of 'common' cardiovascular risk factors, and is responsible for acceleration and worsening of atherothrombosis. Major cardiovascular events cause about 80% of the total mortality in diabetic patients. Diabetes also induces peculiar microangiopathic changes leading to diabetic nephropathy conducive to end-stage renal failure, and to diabetic retinopathy that may progress to vision loss and blindness. In terms of major cardiovascular events, coronary heart disease and ischaemic stroke are the main causes of morbidity and mortality in diabetic patients. Peripheral arterial disease frequently occurs, and is more likely to be conducive to critical limb ischaemia and amputation than in the absence of diabetes. Although there are a number of differences in the pathogenesis and clinical features of diabetic macroangiopathy and microangiopathy, these two entities often coexist and induce mutually worsening effects. Endothelial injury, dysfunction and damage are common starting points for both conditions. Causes of endothelial injury can be distinguished into those 'common' to nondiabetic atherothrombosis, such as hypertension, dyslipidaemia, smoking, hypercoagulability and platelet activation; and those more specific and in some cases…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Endothelial dysfunction may be an underlying cause of many associated vascular problems ( 45 , 54 ).”
From Exercise and Type 2 Diabetes (2010) · cites this paper as [45]
In the citing paper
“Symptoms manifest as neuropathic pain and/or loss of sensation that, coupled with poor blood flow, increase the risk of foot injuries and ulcerations ( 45 , 244 ).”
From Exercise and Type 2 Diabetes (2010) · cites this paper as [45]
In the citing paper
“Diabetic nephropathy develops in ∼30% of individuals with diabetes and is a major risk factor for death in those with diabetes ( 20 , 45 ).”
From Exercise and Type 2 Diabetes (2010) · cites this paper as [45]
In the citing paper
“In addition to traditional risk factors, hyperglycemia, hyperinsulinemia, and oxidative stress contribute to endothelial damage, leading to poor arterial function and greater susceptibility to atherogenesis ( 45 , 82 , 289 ).”
From Exercise and Type 2 Diabetes (2010) · cites this paper as [45]
In the citing paper
“Microalbuminuria, or minute amounts of albumin in the urine, is common and a risk factor for overt nephropathy ( 45 ) and CV mortality ( 91 ).”
From Exercise and Type 2 Diabetes (2010) · cites this paper as [45]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Angiotensin converting enzyme inhibitors in normotensive diabetic patients with microalbuminuria
Lovell, H. G. (1999) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002183 · Cited by 16
RetractedToprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2015) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,533
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
Grundy, S. M., Cleeman, J. I., Merz, C. N. B., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Circulation · doi:10.1161/01.cir.0000133317.49796.0e · Cited by 6,902
Research works printed but not linked: 18
- Rossi, 2005, Heart Int, 1, 18
- Mamcarz, 2004, Pol Arch Med Wewn, 112, 1433
- Dormandy, 1999, Semin Vasc Surg, 12, 138
- Tarchini, 2005, G Ital Nefrol, 22, S15
- Sampson, 1990, Q J Med, 75, 635
- Sun, 1998, Int J Exp Pathol, 79, 207
- Hogikyan, 1998, J Clin Endocrinol Metab, 83, 1946
- Ford-Hutchinson, 1985, Fed Proc, 44, 25
- Ostermann, 1986, Heamostasis, 16, 386
- Lecrubier, 1980, Haemostasis, 9, 43
- Juhan-Vague, 1991, Diabetologia, 34, 457, 10.1007/bf00403280 · DOI · Paper page
- Allemann, 2006, Curr Med Res Opin, 617-, 23
- 1989, Diabetes, 38, 491, 10.2337/diab.38.4.491 · doi:10.2337/diab.38.4.491
- 2002, Circulation, 106, 288
- Lovell, 2001, Cochrane Database Syst Rev, 1, CD002183
- Achour, 2005, JNephrol, 18, 568
- Richter, 2006, Cochrane Database Syst Rev, 18, CD006060
- Keech, 2005, Lancet, 26, 1849
Cited by
Colberg, S. R., Sigal, R. J., Fernhall, B., Regensteiner, J. G., Blissmer, B. J., Rubin, R. R., Chasan-Taber, L., Albright, A. L., & Braun, B. (2010) · Diabetes Care · doi:10.2337/dc10-9990 · Cited by 1,955
“Microalbuminuria, or minute amounts of albumin in the urine, is common and a risk factor for overt nephropathy (45) and CV mortality (91).”
InfluentialEconomic costs of diabetes in the U.S. in 2007
American Diabetes Association (2008) · Diabetes Care · doi:10.2337/dc08-9017 · Cited by 1,323
Economic Costs of Diabetes in the U.S. in 2007
Leahy, J. L. (2008) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(08)79219-9 · Cited by 781
(2010) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3181eeb61c · Cited by 567
“Microalbuminuria, or minute amounts of albumin in the urine, is common and a risk factor for overt nephropathy (45) and CV mortality (91).”
InfluentialThe Role of Aspirin in Cardiovascular Prevention
Gasparyan, A. Y., Watson, T., & Lip, G. Y. H. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.11.080 · Cited by 263
Metadata
- Authors
- Coccheri, S.
- Affiliations
- University of Bologna (IT)
- Corresponding author
- Coccheri, Sergio
- ORCID
- Coccheri, Sergio
- Venue
- Drugs
- Published
- 2007
- Volume
- 67
- Issue
- 7
- Pages
- 997-1026
- ISSN
- 0012-6667 (ISSN-L)
- OpenAlex
- W1986199468
- Cited by
- 139
- References
- 263
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 5 · 2023: 2 · 2022: 5 · 2021: 2 · 2020: 3 · 2019: 4 · 2018: 5 · 2017: 3 · 2016: 7 · 2015: 6 · 2014: 5 · 2013: 12 · 2012: 15
- FWCI
- 2.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Drugs (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- diabetes mellitus, cardiovascular complications, cardiovascular disease prevention, macroangiopathy, microangiopathy, endothelial dysfunction, atherothrombosis, diabetic nephropathy, diabetic retinopathy, peripheral arterial disease, coronary artery disease, ischemic stroke, advanced glycation end products, RAGE, oxidative stress, nitric oxide, renin-angiotensin-aldosterone system, aspirin, picotamide, clopidogrel, antiplatelet therapy, endothelial inflammation
- MeSH terms
- Cardiovascular Diseases, Diabetes Mellitus, Fibrinolytic Agents, Humans, Hypoglycemic Agents, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Approaches to Prevention of Cardiovascular Complications and Events in Diabetes Mellitus. https://app.cochat.ai/papers/10.2165/00003495-200767070-00005
- The paper
- Coccheri, S. (2007). Approaches to Prevention of Cardiovascular Complications and Events in Diabetes Mellitus. Drugs. https://doi.org/10.2165/00003495-200767070-00005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.